Cita APA

Rabaneda, N., Serratosa, J., Bové, J., Vila, M., Saura, J., & Solà, C. (2021). The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson’s disease.

Citación estilo Chicago

Rabaneda, Neus, Joan Serratosa, Jordi Bové, Miquel Vila, Josep Saura, y Carme Solà. The CD200R1 Microglial Inhibitory Receptor As a Therapeutic Target in the MPTP Model of Parkinson’s Disease. 2021.

Cita MLA

Rabaneda, Neus, et al. The CD200R1 Microglial Inhibitory Receptor As a Therapeutic Target in the MPTP Model of Parkinson’s Disease. 2021.